SCHEMBL23577856

SCHEMBL23577856

CCOC(=O)c1cc2c(cc1NC(=O)OC(C)(C)C)n(C)c(=O)n2CC(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GALR2 O43603 1/20 0.36
▸ MITF O75030 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ CCR6 P51684 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ALOX15 P16050 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KCNQ4 P56696 2/20 0.35
▸ KCNQ5 Q9NR82 2/20 0.35
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30035750 1.00 MAPT (0.36) MAPTGAATP53ALDH1A1HPGD
SCHEMBL23590999 0.89 SMN1; SMN2 (0.40) MAPTGAATP53ALDH1A1HPGD
SCHEMBL30034889 0.84 ALDH1A1 (0.43) MAPTGAATP53ALDH1A1HPGD
SCHEMBL23578095 0.84 ALDH1A1 (0.43) MAPTGAATP53ALDH1A1HPGD
SCHEMBL30036541 0.83 KMT2A (0.38) MAPTGAATP53ALDH1A1HPGD
SCHEMBL23577722 0.83 KMT2A (0.38) MAPTGAATP53ALDH1A1HPGD
SCHEMBL30035604 0.79 KMT2A (0.46) MAPTGAAALDH1A1HPGDKMT2A
SCHEMBL23578010 0.79 KMT2A (0.46) MAPTGAAALDH1A1HPGDKMT2A
SCHEMBL23590557 0.79 ALDH1A1 (0.43) MAPTGAAALDH1A1HPGDKMT2A
SCHEMBL30183732 0.79 ALDH1A1 (0.43) MAPTGAAALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081521-B1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LTD (IN) 2025-12-10 — — EP disclosed
CN-115605476-B Substituted tricyclic compounds 鲁宾有限公司 2024-05-24 — — CN disclosed
US-20230119316-A1 Substituted Tricyclic Compounds LUPIN LIMITED (IN) 2023-04-20 — — US disclosed
CN-115605476-A Substituted tricyclic compounds 鲁宾有限公司(IN) 2023-01-13 — — CN disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230119316-A1 Substituted Tricyclic Compounds SOS1, RSU1, KSR1 MAPT 157/4885GAA 2659/4885TP53 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback